Dove DermaSeries

Product NDC: 64942-1306
11-digit product format: 649421306
Labeler code: 64942
Product ID: 64942-1306_ef195fee-89c8-6c8f-e053-2995a90a8b29
Type: HUMAN OTC DRUG
Nonproprietary name: Oatmeal
Dosage form: CREAM
Route: TOPICAL
Labeler: Conopco Inc. d/b/a Unilever
Application: part347
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2013-10-15
Marketing end: 0000-00-00
Substance: OATMEAL
Active strength: 1 g/100mL
Pharmacologic classes: Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Grain Proteins [EXT], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	64942-1306		I	Inactivated by FDA	2026-10-05
excluded package	package	64942-1306	64942-1306-2	I	Inactivated by FDA	2026-10-05
excluded package	package	64942-1306	64942-1306-3	I	Inactivated by FDA	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 33 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	64942-1306-3	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	64942-1306-2	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	64942-1306-3	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	64942-1306-2	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64942-1306-3	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64942-1306-2	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64942-1306-3	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64942-1306-2	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64942-1306-3	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64942-1306-2	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64942-1306-3	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64942-1306-2	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64942-1306-3	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64942-1306-2	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	64942-1306-3	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	64942-1306-2	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	64942-1306-3	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	64942-1306-2	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	64942-1306-2	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	64942-1306-3	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	64942-1306-2	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	64942-1306-3	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
64942-1306-2	2025-01-30	Dove DermaSeries Eczema Therapy Cream
64942-1306-3	2025-01-30	Dove DermaSeries Eczema Therapy Cream
64942-1306-2	2021-04-13	Dove DermaSeries Eczema Therapy Cream
64942-1306-3	2021-04-13	Dove DermaSeries Eczema Therapy Cream
64942-1306-2	2020-01-31	Dove DermaSeries Eczema Therapy Cream
64942-1306-3	2020-01-31	Dove DermaSeries Eczema Therapy Cream

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
64942-1306-1	Dove DermaSeriesEczema Therapy Cream	120 mL in 1 TUBE	CREAM	120	4
64942-1306-2	Dove DermaSeriesEczema Therapy Cream	1 in 1 CARTON	CREAM	1	4
64942-1306-3	Dove DermaSeriesEczema Therapy Cream	15 mL in 1 TUBE	CREAM	15	4

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
OATMEAL	ACTIVE INGREDIENT	8PI54V663Y	DOVE DERMASERIES ECZEMA THERAPY CREAM (OATMEAL) CREAM [CONOPCO INC. D/B/A UNILEVER]	1
OATMEAL	ACTIVE MOIETY	8PI54V663Y	DOVE DERMASERIES ECZEMA THERAPY CREAM (OATMEAL) CREAM [CONOPCO INC. D/B/A UNILEVER]	1
12-HYDROXYSTEARIC ACID	INACTIVE INGREDIENT	933ANU3H2S	DOVE DERMASERIES ECZEMA THERAPY CREAM (OATMEAL) CREAM [CONOPCO INC. D/B/A UNILEVER]	1
CAPRYLYL GLYCOL	INACTIVE INGREDIENT	00YIU5438U	DOVE DERMASERIES ECZEMA THERAPY CREAM (OATMEAL) CREAM [CONOPCO INC. D/B/A UNILEVER]	1
CETEARYL GLUCOSIDE	INACTIVE INGREDIENT	09FUA47KNA	DOVE DERMASERIES ECZEMA THERAPY CREAM (OATMEAL) CREAM [CONOPCO INC. D/B/A UNILEVER]	1
CETOSTEARYL ALCOHOL	INACTIVE INGREDIENT	2DMT128M1S	DOVE DERMASERIES ECZEMA THERAPY CREAM (OATMEAL) CREAM [CONOPCO INC. D/B/A UNILEVER]	1
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	DOVE DERMASERIES ECZEMA THERAPY CREAM (OATMEAL) CREAM [CONOPCO INC. D/B/A UNILEVER]	1
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	DOVE DERMASERIES ECZEMA THERAPY CREAM (OATMEAL) CREAM [CONOPCO INC. D/B/A UNILEVER]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	DOVE DERMASERIES ECZEMA THERAPY CREAM (OATMEAL) CREAM [CONOPCO INC. D/B/A UNILEVER]	1
ISOPROPYL MYRISTATE	INACTIVE INGREDIENT	0RE8K4LNJS	DOVE DERMASERIES ECZEMA THERAPY CREAM (OATMEAL) CREAM [CONOPCO INC. D/B/A UNILEVER]	1
LEMON PEEL	INACTIVE INGREDIENT	72O054U628	DOVE DERMASERIES ECZEMA THERAPY CREAM (OATMEAL) CREAM [CONOPCO INC. D/B/A UNILEVER]	1
LIME PEEL	INACTIVE INGREDIENT	544EQK5Q0W	DOVE DERMASERIES ECZEMA THERAPY CREAM (OATMEAL) CREAM [CONOPCO INC. D/B/A UNILEVER]	1
PETROLATUM	INACTIVE INGREDIENT	4T6H12BN9U	DOVE DERMASERIES ECZEMA THERAPY CREAM (OATMEAL) CREAM [CONOPCO INC. D/B/A UNILEVER]	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	DOVE DERMASERIES ECZEMA THERAPY CREAM (OATMEAL) CREAM [CONOPCO INC. D/B/A UNILEVER]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	DOVE DERMASERIES ECZEMA THERAPY CREAM (OATMEAL) CREAM [CONOPCO INC. D/B/A UNILEVER]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	DOVE DERMASERIES ECZEMA THERAPY CREAM (OATMEAL) CREAM [CONOPCO INC. D/B/A UNILEVER]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	DOVE DERMASERIES ECZEMA THERAPY CREAM (OATMEAL) CREAM [CONOPCO INC. D/B/A UNILEVER]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
64942-1306	DOVE DERMASERIES ECZEMA THERAPY CREAM (OATMEAL) CREAM [CONOPCO INC. D/B/A UNILEVER]	4	Legacy NDC, 3 package rows	20221206_6982a511-5d4f-472e-8e4f-ee250aff3d4f.zip

UNII, Preferred term, Matched term table
UNII	Preferred term	Matched term
8PI54V663Y	OATMEAL	OATMEAL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
240651	colloidal oatmeal 1 % Topical Cream	PSN	6982a511-5d4f-472e-8e4f-ee250aff3d4f	4
1440026	Dove DermaSeries Eczema 1 % Topical Cream	PSN	6982a511-5d4f-472e-8e4f-ee250aff3d4f	4
1440026	colloidal oatmeal 10 MG/ML Topical Cream [Dove DermaSeries Eczema]	SBD	6982a511-5d4f-472e-8e4f-ee250aff3d4f	4
240651	colloidal oatmeal 10 MG/ML Topical Cream	SCD	6982a511-5d4f-472e-8e4f-ee250aff3d4f	4
240651	Avena sativa 1 % Topical Cream	SY	6982a511-5d4f-472e-8e4f-ee250aff3d4f	4
240651	colloidal oatmeal 1 % Topical Cream	SY	6982a511-5d4f-472e-8e4f-ee250aff3d4f	4
1440026	Dove DermaSeries Eczema 1 % Topical Cream	SY	6982a511-5d4f-472e-8e4f-ee250aff3d4f	4
1440026	Dove DermaSeries Eczema 10 MG/ML Topical Cream	SY	6982a511-5d4f-472e-8e4f-ee250aff3d4f	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
64942-1306-1	64942130601	120 mL in 1 TUBE	120 ml					Historical
64942-1306-2	64942130602	1 TUBE in 1 CARTON (64942-1306-2) > 120 mL in 1 TUBE (64942-1306-1)	1 tube	2013-10-15	0000-00-00	No	No	Current
64942-1306-3	64942130603	15 mL in 1 TUBE (64942-1306-3)	15 ml	2013-10-15	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Dove DermaSeries Eczema Therapy Cream	Conopco Inc. d/b/a Unilever	2022-12-05	HUMAN OTC DRUG LABEL	4